The GLP is committed to full transparency. Download and review our Annual Report.

On the verge of stem cell “cure” for macular degeneration

Sufferers of an incurable form of a common age-related eye disease that leads to blindness could soon be cured, thanks to ground-breaking stem cell research.

Developmental biologist and Nobel laureate Professor John Gurdon says that stem cell replacement therapy for the dry form of macular degeneration has been shown to “work quite well” in animals and is now being tested in humans.

Speaking in Hong Kong, the 80-year-old Gurdon said: “My understanding is that the permission to offer this as a therapeutic treatment is about six months away. The trials in humans take about three months to see if they’re successful, and then after that it should really be no problem in making [the treatment] available to patients.”

Read the full, original story: Stem cell researchers on brink of cure for macular degeneration

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend